During the past decade, Montefiore Medical Center, Albert Einstein College of Medicine conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 12 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 9 clinical trials were completed. i.e. 69.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Montefiore Medical Center, Albert Einstein College of Medicine" #1 sponsor was "Montefiore Medical Center" with 10 trials, followed by "Albert Einstein College of Medicine" with 5 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials sponsored, "Beth Israel Deaconess Medical Center" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Montefiore Medical Center, Albert Einstein College of Medicine" #1 collaborator was "Albert Einstein College of Medicine" with 4 trials as a collaborator, "Montefiore Medical Center" with 4 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 3 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator and "Dana-Farber Cancer Institute" with 2 trials as a collaborator. Other collaborators include 61 different institutions and companies that were collaborators in the rest 60 trials.

According to Clinical.Site data, the most researched conditions in "Montefiore Medical Center, Albert Einstein College of Medicine" are "HIV Infections" (3 trials), "Prader-Willi Syndrome" (3 trials), "Autism Spectrum Disorder" (2 trials), "Coronary Artery Disease" (2 trials) and "Diabetic Nephropathies" (2 trials). Many other conditions were trialed in "Montefiore Medical Center, Albert Einstein College of Medicine" in a lesser frequency.

Most popular intervention types in "Montefiore Medical Center, Albert Einstein College of Medicine" are "Drug" (39 trials), "Other" (11 trials), "Biological" (5 trials), "Behavioral" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Allopurinol" (2 trials), "Ganaxolone" (2 trials), "Intranasal Oxytocin (IN-OXT)" (2 trials) and "Lamivudine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Montefiore Medical Center, Albert Einstein College of Medicine" are 50 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Montefiore Medical Center, Albert Einstein College of Medicine". undefined are not yet recruiting, 15 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in Montefiore Medical Center, Albert Einstein College of Medicine, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Montefiore Medical Center, Albert Einstein College of Medicine, 6 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 9 trials that are defined as “Not Applicable".